Angiotensin II inhibits glucose uptake of skeletal muscle via the adenosine monophosphate-activated protein kinase pathway

Journal of the American Society of Hypertension

Volumn 1, Issue 4, 2007, Pages 251-255

  Shinshi, Yasuyuki ^a   Higashiura, Katsuhiro ^a   Yoshida, Daisuke ^a   Togashi, Nobuhiko ^a   Yoshida, Hideaki ^a   Miyazaki, Yoshinori ^a   Ura, Nobuyuki ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AMP activated protein kinase; hypertension; insulin resistance; renin angiotensin system

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; FRUCTOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; TUMOR NECROSIS FACTOR ALPHA; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORRELATION FUNCTION; EX VIVO STUDY; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; IN VIVO STUDY; INCUBATION TIME; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SKELETAL MUSCLE; SOLEUS MUSCLE; SPRAGUE DAWLEY RAT;

EID: 34447645100     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2007.04.007     Document Type: Article

References (18)

1. Hardie D.G., Carling D., and Halford N. Roles of the Snf1/Rkin1/AMP-activated protein kinase family in the response to environmental and nutritional stress. Semin Cell Biol 5 (1994) 409-416
2. Hardie D.G., and Carling D. The AMP-activated protein kinase: fuel gauge of the mammalian cell?. Eur J Biochem 246 (1997) 259-273
3. Hayashi T., Hirshman M.F., Kurth E.J., Winder W.W., and Goodyear L.J. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47 (1998) 1369-1373
4. Merrill G.F., Kurth E.J., Hardie D.G., and Winder W.W. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273 (1997) E1107-E1112
5. Furuhashi M., Ura N., Takizawa H., Yoshida D., Moniwa N., Murakami H., et al. Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. J Hypertens 22 (2004) 1977-1982
6. Folli F., Kahn C.R., Hansen H., Bouchie J.L., and Feener E.P. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. J Clin Invest 100 (1997) 2158-2169
7. Henriksen E.J., Jacob S., Kinnick T.R., Teachey M.K., and Krekler M. Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 38 (2001) 884-890
8. Togashi N., Ura N., Higashiura K., Murakami H., and Shimamoto K. The contribution of skeletal muscle tumor necrosis factor-α to insulin resistance and hypertension in fructose-fed rats. J Hypertens 18 (2000) 1605-1610
9. Bergeron R., Russell III R.R., Young L.H., Ren J.M., Marcucci M., Lee A., et al. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 276 (1999) E938-E944
10. Fryer L.G., Parbu-Patel A., and Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277 (2002) 25226-25232
11. Russell III R.R., Bergeron R., Shulman G.I., and Young L.H. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277 (1999) H643-H649
12. Kurth-Kraczek E.J., Hirshman M.F., Goodyear L.J., and Winder W.W. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48 (1999) 1667-1671
13. Bergeron R., Previs S.F., Cline G.W., Perret P., Russell III R.R., Young L.H., et al. Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 50 (2001) 1076-1082
14. Koistinen H.A., Galuska D., Chibalin A.V., Yang J., Zierath J.R., Holman G.D., et al. 5-aminoimidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52 (2003) 1066-1072
15. Kamide K., Rakugi H., Higaki J., Okamura A., Nagai M., Moriguchi K., et al. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. Am J Hypertens 15 (2002) 66-71
16. Steen M.S., Foianini K.R., Youngblood E.B., Kinnick T.R., Jacob S., and Henriksen E.J. Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats. J Appl Physiol 86 (1999) 2044-2051
17. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
18. Yamaguchi K., Higashiura K., Ura N., Murakami H., Hyakukoku M., Furuhashi M., et al. The effect of TNF-α on tissue specificity and selectivity to insulin signaling. Hypertens Res 26 (2003) 389-396